Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 2/2011

01-04-2011 | Letter to the Editor

REPLY to ASTRAL Letter

Authors: Heiko Alfke, Klinikum Luedenscheid

Published in: CardioVascular and Interventional Radiology | Issue 2/2011

Login to get access

Excerpt

With interest I read the comment of the authors of the ASTRAL trial to my critical statement [1, 2]. First of all, I want to make it clear that I have high respect for the efforts of all of the trial participants to conduct such a large clinical trial that dealt with an important disease and tried to answer a difficult question. However, it is our duty as physicians to look carefully at the study design and the published data to extract the best possible evidence for our patients. …
Literature
1.
go back to reference The ASTRAL Trial Investigators (2009) Revascularization versus best medical therapy for renal artery stenosis. N Engl J Med 361:1952–1962 The ASTRAL Trial Investigators (2009) Revascularization versus best medical therapy for renal artery stenosis. N Engl J Med 361:1952–1962
2.
go back to reference Alfke H, Radermacher J (2010) Renal artery stenting is no longer indicated after ASTRAL: pros and cons. Cardiovasc Intervent Radiol 33:883–886PubMedCrossRef Alfke H, Radermacher J (2010) Renal artery stenting is no longer indicated after ASTRAL: pros and cons. Cardiovasc Intervent Radiol 33:883–886PubMedCrossRef
3.
go back to reference Controversies––the ASTRAL trial. (2002) J Renovasc Dis 1:19–23 Controversies––the ASTRAL trial. (2002) J Renovasc Dis 1:19–23
Metadata
Title
REPLY to ASTRAL Letter
Authors
Heiko Alfke
Klinikum Luedenscheid
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 2/2011
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-011-0116-z

Other articles of this Issue 2/2011

CardioVascular and Interventional Radiology 2/2011 Go to the issue